Effects of enzyme inhibitors on junction potentials in response to adrenergic nerve stimulation.
D000818:Animals; D002396:Catechols; D004594:Electrophysiology; D005453:Fluorescence; D006168:Guinea Pigs; D006651:Histocytochemistry; D006834:Hydrazines / Q000494:pharmacology; D007001:Hypogastric Plexus / Q000502:physiology; D007275:Injections, Intravenous; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D011748:Pyrogallol / Q000494:pharmacology; D012669:Seminal Vesicles / Q000294:innervation / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects*; D014166:Transferases / Q000494:pharmacology*
D002396:Catechols; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D011748:Pyrogallol; D010830:Physostigmine; D007490:Iproniazid; D014166:Transferases